Header links

Institute
Research
Talent
Clinical trials
Innovation
Core Facilities
Society

Estudio de fase II, multicéntrico, abierto y de un solo brazo para evaluar la seguridad y eficacia de asciminib en participantes

Estudio de fase II, multicéntrico, abierto y de un solo brazo para evaluar la seguridad y eficacia de asciminib en participantes pediátricos con leucemia mieloide crónica cromosoma Filadelfia positivo en fase crónica (LMC Ph+ en FC) de nuevo diagnóstico o tratada previamente con o sin mutación T315I.

Contact

Protocol code: CABL001I12202
EudraCT code: No aplica
Pathology: Tumors
Principal investigator: Murciano Carrillo, Thaïs
Research group: Càncer i malalties hematològiques infantils
Service: Oncohematologia Pediàtrica
Phase: Fase II
Recruiting: Open
Status: Iniciat

Contact Form

Name*

First surname*

Second surname

Email address*

Telephone*

Write your question*

I have read and accept the data protection policy *.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information

The request for information on a research project or clinical trial does not entail inclusion in it.